PPQ-102
CAS No. 931706-15-9
PPQ-102( CFTR Inhibitor IV | Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV )
Catalog No. M16668 CAS No. 931706-15-9
PPQ-102 is a potent CFTR inhibitor which can completely inhibited CFTR chloride current with IC 50approximately 90 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 81 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 269 | In Stock |
|
| 50MG | 456 | In Stock |
|
| 100MG | 730 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePPQ-102
-
NoteResearch use only, not for human use.
-
Brief DescriptionPPQ-102 is a potent CFTR inhibitor which can completely inhibited CFTR chloride current with IC 50approximately 90 nM.
-
DescriptionPPQ-102 is a potent CFTR inhibitor which can completely inhibited CFTR chloride current with IC 50approximately 90 nM.
-
In VitroCell Viability Assay Cell Line:E13.5 embryonic kidneys (embryonic kidney organ culture model of PKD)Concentration:0, 0.5, 5 μM Incubation Time:3 or 4 days Result:Remarkablyreduced the number and size of renal cysts formed in the 8-Br-cAMP-containing medium (showed ~60% inhibition of cyst formation at 0.5 μM, near complete absence of cysts at 2.5 and 5 μM).Remarkable reduced cyst size over 1 and 2 days in the 8-Br-cAMP-containing medium.
-
In Vivo——
-
SynonymsCFTR Inhibitor IV | Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV
-
PathwayApoptosis
-
TargetCFTR
-
RecptorCFTR
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number931706-15-9
-
Formula Weight438.48
-
Molecular FormulaC26H22N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 5 mg/mL
-
SMILESO=C1N(C)C(C(C(N1C)=O)=C2C3=CC=CC=C3)=C4N2C5=C(C=CC=C5)NC4C6=CC=C(C)O6
-
Chemical Name7,9-dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-5,6-dihydropyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(7H,9H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tradtrantip L, et al. J Med Chem. 2009 Oct 22;52(20):6447-55.
molnova catalog
related products
-
GLPG-2222
GLPG-2222 (ABBV-2222, Galicaftor)?is a novel potent and efficacious CFTR corrector with EC50 of 5 nM; is highly potent (5 nM) and efficacious in cells from multiple CF patient donors that have F508del homozygous mutation.
-
VRT-532
VRT-532 (CFpot-532) is an effective modulator of CFTR and is commonly used in studies of cystic fibrosis (CF) caused by CFTR defects.
-
Olacaftor
Olacaftor (VX-440, VX440) is a next-generation CFTR corrector, shows the potential to enhance the amount of CFTR protein at the cell’s surface and for treatment of cystic fibrosis.
Cart
sales@molnova.com